Аутоиммунный гепатит во время беременности: вопросы эпидемиологии, клиники, диагностики, терапии, материнских и перинатальных исходов

1. Westbrook R.H., Yeoman A.D., Kriese S., Heneghan M.A. Outcomes of pregnancy in women with autoimmune hepatitis. J. Autoimmunity. 2012; 38(2-3): J239-44. https://dx.doi.org/10.1016/j.jaut.2011.12.002
2. Pena Polanco N.A., Levy C. Autoimmune hepatitis and pregnancy. Clin. Liver Dis. (Hoboken). 2024; 23(1): e0112. https://dx.doi.org/10.1097/CLD.0000000000000112
3. Chung Y.Y., Heneghan M.A. Autoimmune hepatitis in pregnancy: pearls and pitfalls. Hepatology. 2022; 76(2): 502-17. https://dx.doi.org/10.1002/hep.32410
4. Bozward A.G., Wootton G.E., Podstawka O., Oo Y.H. Autoimmune hepatitis: Tolerogenic immunological state during pregnancy and immune escape in post-partum. Front. Immunol. 2020; 11: 591380. https://dx.doi.org/fimmu.2020.591380
5. Fischer S.E., de Vries E.S., Tushuizen M.E., de Boer Y.S., van der Meer A.J.P., de Man R.A. et al. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis. Liver International. 2023; 43: 855-64. https://dx.doi.org/10.1111/liv.15511
6. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J. Hepatol. 2022; 77(3): 761-806. https://dx.doi.org/10.1016/j.jhep.2022.05.011
7. Mack C.L., Adams D., Assis D.N., Kerkar N., Manns M.P., Mayo M.J. et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020; 72(2): 671-722. https://dx.doi.org/10.1002/hep.31065
8. Sajja S., Idler J., Saad J., Bahado-Singh R. Acute liver failure in pregnancy due to autoimmune hepatitis. BMJ Case Rep. 2021; 14(8): e241355. https://.doi.org/10.1136/bcr-2020-241355
9. Dalekos G.N., Papatheodoridis G.V., Koskinas J., Goulis I., Rigopoulou E.I., Tiniakos D. Hellenic Association for the Study of the Liver (HASL): revised clinical practice guidelines for autoimmune hepatitis. Ann. Gastroenterol. 2024; 37(6): 623-54. https://dx.doi.org/10.20524/aog.2024.0924
10. Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clin. Mol. Hepatol. 2023; 29(3): 542-92. https://dx.doi.org/10.3350/cmh.2023.0087
11. Sarkar M., Brady C.W., Fleckenstein J., Forde K.A., Khungar V., Molleston J.P. et al. Reproductive health and liver disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021; 73(1): 318-65. https://dx.doi.org/10.1002/hep.31559
12. Kothadia J.P., Shah J.M. Autoimmune hepatitis and pregnancy. 2023 Feb 6. In: StatPearls
13. Gonsalkorala E.S., Cannon M.D., Lim T.Y., Penna L., Willliamson C., Heneghan M.A. Non-invasive markers (ALBI and APRI) predict pregnancy outcomes in women with chronic liver disease. Am. J. Gastroenterol. 2019; 114(2): 267-75. https://dx.doi.org/10.1038/s41395-018-0181-x
14. Wang C.W., Grab J., Tana M.M., Irani R.A., Sarkar M. Outcomes of pregnancy in autoimmune hepatitis: A population-based study. Hepatology. 2022; 75(1): 5-12. https://dx.doi.org/10.1002/hep.32132
15. Sharma R., Simon T.G., Stephansson O., Verna E.C., Emond J., Söderling J. et al. Pregnancy outcomes in women with autoimmune hepatitis – A nationwide population-based cohort study with histopathology. Clin. Gastroenterol. Hepatol. 2023; 21(1): 103-114.e110. https://dx.doi.org/10.1016/j.cgh.2021.12.024
16. Hahn J.W., Yang H.R., Moon J.S., Chang J.Y., Lee K., Kim G.A. et al. Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis. EClinicalMedicine. 2023; 65: 102280. https://dx.doi.org/10.1016/j.eclinm.2023.102280
17. Meng Z., Yang Y.J. Advances in the treatment of autoimmune hepatitis. Clin. Transl. Hepatol. 2024; 12(10): 878-85. https://dx.doi.org/10.14218/jcth.2024.00193
18. Lamba M., Ngu J.H., Stedman C.A.M. Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis. Clin. Gastroenterol. Hepatol. 2021; 19(3): 573-9. https://dx.doi.org/10.1016/j.cgh.2020.05.061
19. EASL Clinical Practice Guidelines: Autoimmune hepatitis. J. Hepatol. 2015; 63(4): 971-1004. https://dx.doi.org/10.1016/j.jhep.2015.06.030
20. Rahim M.N., Theocharidou E., Yen Lau K.G., Ahmed R., Marattukalam F., Long L. et al. Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients. J. Hepatol. 2021;74(6):1407-15. https://dx.doi.org/10.1016/j.jhep.2020.12.022
21. El Jamaly H., Eslick G.D., Weltman M. Systematic review with meta-analysis: Autoimmune hepatitis in pregnancy. Scand. J. Gastroenterol. 2021; 56(10): 1194-204. https://dx.doi.org/10.1080/00365521.2021.1953127
22. Caballero-Mateos A.M., López Garrido M., Becerra Massare P., de Teresa Galván J. Autoimmune severe acute fulminant hepatic failure (FHF) during pregnancy. Gastroenterol. Hepatol. 2018; 41(4): 259-60. https://dx.doi.org/10.1016/j.gastrohep.2017.04.001
23. Stokkeland K., Ludvigsson J.F., Hultcrantz R., Ekbom A., Höijer J., Bottai M. et al. Increased risk of preterm birth in women with autoimmune hepatitis—A nationwide cohort study. Liver Int. 2016; 36(1): 76-83. https://dx.doi.org/10.1111/liv.12901
24. Крышня М.А., Мозговая Е.В. Функциональные расстройства печени I триместра беременности. Акушерство и гинекология. 2022; 11: 14-22.
25. Li X., Zhang J., Malik S., Jain A., Wang M., Niu C. Maternal and fetal outcomes of autoimmune hepatitis in pregnancy: A United States hospitalized patient study. Clin. Res. Hepatol. Gastroenterol. 2025; 49(3): 102544. https://dx.doi.org/110.1016/j.clinre.2025.102544

Поступила 07.07.2025

Принята в печать 25.11.2025